TYRA (STOCKS)
Tyra Biosciences, Inc. Common Stock
$35.620000
+0.360000 (+1.02%)
Prev close: $35.260000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Todd J. Harris
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,918.21M
- Employees
- 60
- P/E (TTM)
- -17.70
- P/B (TTM)
- 7.31
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Analyst Recommendations
8
Strong Buy
9
Buy
1
Hold
0
Sell
Recent News
No recent news found for this ticker.
Earnings Surprises
| Period | Actual | Estimate | Surprise | Surprise % |
|---|---|---|---|---|
|
Dec 2025 (Q4)
|
$-0.57 | $-0.54 | -0.0313 | -5.81% |
|
Sep 2025 (Q3)
|
$-0.50 | $-0.51 | +0.0075 | +1.48% |
|
Jun 2025 (Q2)
|
$-0.47 | $-0.54 | +0.0693 | +12.85% |
|
Mar 2025 (Q1)
|
$-0.47 | $-0.50 | +0.0294 | +5.89% |
Financial Statements
| Revenues | $0.00 |
| Nonoperating Income/Loss | $12.82M |
| Operating Expenses | $132.76M |
| Research and Development | $102.93M |
| Other Operating Expenses | $29.83M |
| Operating Income/Loss | -$132.76M |
| Income/Loss From Continuing Operations After Tax | -$119.95M |
| Income/Loss From Continuing Operations Before Tax | -$119.95M |
| Income Tax Expense/Benefit | $0.00 |
| Net Income/Loss | -$119.95M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$119.95M |
| Net Income/Loss Available To Common Stockholders, Basic | -$119.95M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$2.01 |
| Diluted Earnings Per Share | -$2.01 |
| Basic Average Shares | 59,602,328 |
| Diluted Average Shares | 59,602,328 |
| Assets | $282.61M |
| Current Assets | $265.45M |
| Noncurrent Assets | $17.16M |
| Fixed Assets | $1.31M |
| Other Non-current Assets | $15.85M |
| Liabilities | $23.43M |
| Current Liabilities | $18.09M |
| Accounts Payable | $1.18M |
| Other Current Liabilities | $16.92M |
| Noncurrent Liabilities | $5.34M |
| Equity | $259.18M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $259.18M |
| Liabilities And Equity | $282.61M |
| Net Cash Flow From Operating Activities | -$95.14M |
| Net Cash Flow From Operating Activities, Continuing | -$95.14M |
| Net Cash Flow From Investing Activities | $72.46M |
| Net Cash Flow From Investing Activities, Continuing | $72.46M |
| Net Cash Flow From Financing Activities | $8.10M |
| Net Cash Flow From Financing Activities, Continuing | $8.10M |
| Net Cash Flow | -$14.58M |
| Net Cash Flow, Continuing | -$14.58M |
| Comprehensive Income/Loss | -$120.32M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$120.32M |
| Other Comprehensive Income/Loss | -$120.32M |